fbpx
spot_img
Thursday, November 14, 2024
More
    spot_img

    FDA Vaccine Advisory Committee rejects Pfizer’s application for booster shots

    Must Read

    GNB Desk
    GNB Desk
    A global media for the latest news, entertainment, music fashion, and more.
    Follow us

    FDA’s Vaccines and Related Biological Products Advisory Committee on Friday rejected Pfizer-BioNTech’s supplemental Biologics License Application for the administration of a third dose, or “booster” dose, of the COVID-19 vaccine in individuals 16 years of age and older, saying the committee needs more data.

    The vote by the Vaccines and Related Biological Products Advisory Committee was 16-2.

    The Vaccines and Related Biological Products Advisory Committee was on a virtual meeting since early Friday morning to discuss whether the data presented by Pfizer support the safety and effectiveness of a booster dose of COMIRNATY administered 6 months post-primary vaccination series.

    The meeting is continuing and there may be another vote on boosters for a limited age group.

    (This is a breaking story and will be updated)

    Comments
    - Advertisement -spot_img
    - Advertisement -

    Latest News

    Elon Musk and Vivek Ramaswamy to Lead Trump’s Efficiency Initiative

    In a statement released on November 12, 2024, President-Elect Donald J. Trump announced a groundbreaking initiative aimed at overhauling...
    - Advertisement -spot_img

    More Articles

    - Advertisement -spot_img